VJHemOnc is committed to improving our service to you

SOHO 2020 | COVID-19 impact on AML: German perspective

VJHemOnc is committed to improving our service to you

Marion Subklewe

Marion Subklewe, MD, Ludwig-Maximilians-University of Munich, Munich, Germany, discusses the impact of the COVID-19 on the treatment and management of patients with acute myeloid leukemia (AML) in Germany. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter